Patterns of cardiovascular pathology induced by diverse cardioactive drugs

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 547-552

  Greaves, Peter ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Arterial toxicity; Dog histopathology; Vasoactive drugs

Indexed keywords

ALIPHATIC AMINE; ANOREXIGENIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT; CATECHOLAMINE DERIVATIVE; DIGOXIN; ENDOTHELIN RECEPTOR ANTAGONIST; ERGOT ALKALOID; HYPERTENSIVE AGENT; MITOMYCIN C; MONOCROTALINE;

ANIMAL MODEL; ANIMAL TISSUE; BLEEDING; BLOOD VESSEL INJURY; CARDIOTOXICITY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG ABUSE; HEART MUSCLE NECROSIS; HYPERTENSION; HYPOTENSION; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA;

ANIMALS; ARTERITIS; CARDIOVASCULAR AGENTS; DOGS; ENDOTHELINS; HUMANS; HYPERTENSION; HYPOTENSION; MUSCLE, SMOOTH, VASCULAR;

CANIS FAMILIARIS;

EID: 0034653408     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00222-2     Document Type: Conference Paper

References (33)

1. Albassam M.A., Metz A.L., Gragtmans N.J., King L.M., Macallum G.E., Halluk H., McGuire E.J. Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist. Toxicol. Pathol. 27:1999;156-164.
2. Bloor C.M., Lowman R.M. Experimental coronary arteriography. 1. The distribution and extent of allylamine-induced vascular lesions in the dog. Radiology. 81:1963;770-777.
3. Boor P.J., Gotlieb A.I., Joseph E.C., Kerns W.D., Roth R.A., Tomaszewski K.E. Chemical-induced vascular injury. Toxicol. Appl. Pharmacol. 132:1995;177-195.
4. Bourdois P.S., Dancla J.-L., Faccini J.M., Nachbaur J., Monro A.M. The subacute toxicology of digoxin in dogs: clinical chemistry and histopathology of heart and kidneys. Arch. Toxicol. 51:1982;273-283.
5. Byrom, F.B., 1954. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension. Experimental evidence from the hypertensive rat. Lancet 2, 201-211.
6. Calabrese L.H., Duna G.F. Drug-induced vasculitis. Curr. Opin. Rheumatol. 8:1996;34-40.
7. Caplan L.R., Hier D.B., Banks G. Current concepts of cerebrovascular disease-stroke: stroke and drug abuse. Stroke. 13:1982;869-872.
8. Citron B.P., Halpern M., McCarron M., Lundberg G.D., McCormick R., Pincus I.J., Tatter D., Haverback B.J. Necrotizing angiitis associated with drug abuse. New Engl. J. Med. 283:1970;1003-1011.
9. Conrad L.L., Gonzalez I.E., Joel W., Furman R.H. Histochemical evaluation of canine coronary artery and aortic lesions induced by intravenous allylamine. Circ. Res. 4:1956;263-267.
10. Greaves P. Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans. Exp. Toxicol. Pathol. 50:1998;283-293.
11. Griffith R.W., Grauwiler J., Hodel C., Leist K.H., Matter B. Toxicologic considerations - ergot alkaloids and related compounds. Handbook of Experimental Pharmacology. 49:1978;805-851 Springer, Berlin.
12. Hackel D.B., Reimer K.A. Role of recreational and therapeutic drugs in occurrence of sudden death. Cardiovasc. Rev. Rep. 15:1994;16-34.
13. Jeanette J.C., Falk R.J. Small vessel vasculitis. New Engl. J. Med. 337:1997;1512-1523.
14. Joris I., Majno G. Medial changes in arterial spasm induced by L-norepinephrine. Am. J. Pathol. 105:1981;212-222.
15. Manson J.E., Faich G.A. Pharmacotherapy for obesity-do the benefits outweigh the risks? New Engl. J. Med. 335:1996;659-660.
16. Mesfin G.M., Higgins M.J., Robinson F.G., Zhong W.-Z. Relationship between serum concentrations, hemodynamic effects, and cardiovascular lesions in dogs treated with minoxidil. Toxicol. Appl. Pharmacol. 140:1996;337-344.
17. Mesfin G.M., Shawaryn G.G., Higgins M.J. Cardiovascular alterations in dogs treated with hydralazine. Toxicol. Pathol. 15:1987;409-416.
18. Mesfin G.M., Robinson F.G., Higgins M.J., Zhong W.-Z., Ducharme D.W. The pharmacological basis of the cardiovascular toxicity of minoxidil in the dog. Toxicol. Pathol. 23:1995;498-506.
19. Nemes Z., Dietz R., Mann J.F.E., Lüth J.B., Gross F. Vasoconstriction and increased blood pressure in the development of accelerated vascular disease. Virchows Arch. A386:1980;161-173.
20. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell Cardiol. 17:1985;291-306.
21. Rona G., Zsoter T., Chappel C., Gaudry R. Myocardial lesions, circulatory and electrocardiographic changes produced by isoproterenol in the dog. Rev. Can. Biol. 18:1959;83-94.
22. Sandusky G.E., Means J.R., Todd G.C. Comparative cardiovascular toxicity in dogs given inotropic agents by continuous intravenous infusion. Toxicol. Pathol. 18:1990;268-278.
23. Smith C.C., Zeek P.M., McGuire J. Periarteritis nodosa in experimental hypertensive rats and dogs. Am. J. Pathol. 20:1944;721-735.
24. Sneller M.C., Fauci A.S. Pathogenesis of vasculitis syndromes. Med. Clin. North Am. 81:1997;221-242.
25. Spencer A., Greaves P. Periarteritis in a beagle colony. J. Comp. Pathol. 97:1987;122-128.
26. Steiness E., Bille-Brahe N.E., Hansen J.F., Lomholt N., Ring-Larsen H. Reduced myocardial blood flow in acute and chronic digitalization. Acta Pharmacol. Toxicol. 43:1978;29-35.
27. Stejskal V., Havu N., Malmfors T. Necrotising vasculitis as an immunological complication in toxicity study. Arch. Toxicol. Suppl. 5:1982;283-286.
28. Stepanek J., Zak F. Zweijährige perorale Applikation von Aminorex am Hund. 2 Teil. Z. Kardiol. 64:1975;768-781.
29. Szakács J.E., Cannon A. L-norepinephrine myocarditis. Am. J. Clin. Pathol. 30:1958;425-434.
30. Teske R.H., Bishop S.P., Righter H.F., Detweiler D.K. Subacute digoxin toxicosis in the beagle dog. Toxicol. Appl. Pharmacol. 35:1976;283-301.
31. Uprichard A.C.G., Metz A.L., Halluk H., Haleen S.J. PD-156707: a selective endothelin-A receptor antagonist. Cardiovasc. Drug Rev. 16:1998;89-104.
32. Waters L.L., deSuto-Nagy G.I. Lesions of the coronary arteries and great vessels of the dog following injection of adrenaline: their prevention by dibenamine. Science. 111:1950;634-635.
33. Wilens S.L. Enhancement of serum sickness lesions in rabbits with pressor agents. Arch. Pathol. 80:1965;590-603.